704 related articles for article (PubMed ID: 28476121)
1. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
Velentzis LS; Salagame U; Canfell K
BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of hormone therapy in the United States.
Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
J Womens Health (Larchmt); 2009 Oct; 18(10):1669-77. PubMed ID: 19857096
[TBL] [Abstract][Full Text] [Related]
4. What the Women's Health Initiative has taught us about menopausal hormone therapy.
Chester RC; Kling JM; Manson JE
Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination.
Wegienka G; Havstad S; Kelsey JL
J Womens Health (Larchmt); 2006 May; 15(4):369-78. PubMed ID: 16724885
[TBL] [Abstract][Full Text] [Related]
6. What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations.
Long L; Briscoe S; Cooper C; Hyde C; Crathorne L
Health Technol Assess; 2015 Jan; 19(8):1-134. PubMed ID: 25629427
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
F1000Res; 2019; 8():. PubMed ID: 31543950
[TBL] [Abstract][Full Text] [Related]
8. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
Harman SM
Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China.
Tamlyn Anne R; Downes M; Simoncini T; Yu Q; Ren M; Wang Y; Graziano CM; Kim K
J Med Econ; 2024; 27(1):16-26. PubMed ID: 38037348
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.
Crawford SL; Crandall CJ; Derby CA; El Khoudary SR; Waetjen LE; Fischer M; Joffe H
Menopause; 2018 Dec; 26(6):588-597. PubMed ID: 30586004
[TBL] [Abstract][Full Text] [Related]
12. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
13. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
[TBL] [Abstract][Full Text] [Related]
14. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and breast cancer.
Santen RJ
J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trial.
Zethraeus N; Borgström F; Jönsson B; Kanis J
Int J Technol Assess Health Care; 2005; 21(4):433-41. PubMed ID: 16262965
[TBL] [Abstract][Full Text] [Related]
18. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.
Roth JA; Etzioni R; Waters TM; Pettinger M; Rossouw JE; Anderson GL; Chlebowski RT; Manson JE; Hlatky M; Johnson KC; Ramsey SD
Ann Intern Med; 2014 May; 160(9):594-602. PubMed ID: 24798522
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
20. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
Huang WF; Tsai YW; Hsiao FY; Liu WC
BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
